Oxis Turbohaler 12mcg

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Formoterol Fumarate Dihydrate
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

PA1019/015/002

12 Mcg/Dose

R03AC13

Powder for Inhalation

Product Notice

Supply of Oxis 12mcg powder for inhalation to the Irish market will be discontinued by February 2024.